Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by mungermanon Jul 14, 2020 7:52pm
151 Views
Post# 31268198

RE:Concerns I have with ACB.

RE:Concerns I have with ACB.

Daredevil1964 wrote: IMO the market share that one would get by merging with ACB is not guarenteed. There is still the factor about massive write downs still on behalf of ACB. ACB is still not even EBDITA positive. ACB just went thru a reverse split 12/1 to remain on the stock exchange. Possible share dilution may be on the horizon as well to raise cash. The best thing ACB has done recently is acquire Reliva. That I must admitt is a good move.
There are far better acquisitions that have a lot less risk to them. I can only say that perhaps Irwin saw the ACB books and maybe thru off ACB with a ridiculous compensation and board seating to get out of the posibility of a merger. Maybe, he backed out that way. He got to see his competitors books. I would like to believe that, but I am not convinced. A deal of that nature really does not bring anything to the table for Aphria IMO.
Now if Irwin asked for a billion dollars to set up a deal that would bring an MSO onboard inparticular a partnership with Curaleaf or Trulieve then I am all for it. An MSO with potentially a second to none footprint for the sale of medical MJ. Or, possible purchase a similar distribution business like Reliva in the US. But, most of all let's go after a CPG in the US. Again, this all speculation, but if the Democrats can get the Senate in November, the topic of US legalization is going to be a new hot topic. Irwin needs to act in our best interests, and what is our best interests is a strategy into the United States. IMO.

 

"He got to see his competitors books.".... this has definitly ran through my mind. they seen each others books, aphria got majority share (when their stock price was slightly lower) and the deal broke down. however i dont think it was Irwins compensation that was the problem. he would have been CEO he could have changed his salary to anything. its the buyout target that wanted better compensation. If a deal doesnt go through, i'll take that as a sign of strength/confidence from Aphria mangement because it was them who turned down the deal.

 

i agree with everything else you said esspecially the CPG and MSO thoughts

Bullboard Posts